Cargando…
A systematic review of laser therapy for vulvovaginal atrophy/genitourinary syndrome of menopause in breast cancer survivors
Women who have been treated for breast cancer may experience vulvo-vaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM). This is a progressive condition and will not improve without treatment. Whilst vaginal oestrogen is the most effective treatment for GSM, many breast cancer survivors a...
Autores principales: | Knight, Charity, Logan, Vera, Fenlon, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974376/ https://www.ncbi.nlm.nih.gov/pubmed/32010212 http://dx.doi.org/10.3332/ecancer.2019.988 |
Ejemplares similares
-
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women
por: Nappi, Rossella E., et al.
Publicado: (2019) -
Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
por: Edwards, D., et al.
Publicado: (2016) -
The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state‐of‐the‐art review
por: Mortensen, Olivia Engholt, et al.
Publicado: (2022) -
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy
por: Cucinella, Laura, et al.
Publicado: (2023) -
An online survey on coping methods for genitourinary syndrome of menopause, including vulvovaginal atrophy, among Japanese women and their satisfaction levels
por: Ohta, Hiroaki, et al.
Publicado: (2023)